PATRICIA RAMBO: Open Payments
NPI 1962011353 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 46 payments from 9 companies in 2025. Trend: 2023 $1,082 · 2024 $569 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $236 |
| Lilly USA, LLC | 11 | $169 |
| AstraZeneca Pharmaceuticals LP | 7 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| PFIZER INC. | 3 | $55 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: MOUNJARO, Rybelsus, JARDIANCE, Ozempic, FARXIGA, Kerendia, Wegovy, BREZTRI.
Industry payments across TX — which companies pay providers there.
